Literature DB >> 7755719

A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.

T Kishimoto1, R V Pearse, C R Lin, M G Rosenfeld.   

Abstract

Corticotropin-releasing factor (CRF) mediates many critical aspects of the physiological response to stress. These effects are elicited by binding to specific high-affinity receptors, which are coupled to guanine nucleotide stimulatory factor (Gs)-response pathways. Recently, a gene encoding a receptor for CRF, expressed in pituitary and the central nervous system (PC-CRF receptor), was isolated and characterized. Here we report the identification and characterization of a second, distinct CRF receptor that is expressed primarily in heart and skeletal muscle and exhibits a specific ligand preference and antagonist sensitivity compared with the PC-CRF receptor. We refer to this second receptor as the heart/muscle (HM)-CRF receptor.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7755719      PMCID： PMC42647          DOI： 10.1073/pnas.92.4.1108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  38 in total

1.  Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study.

Authors:  E B De Souza; T R Insel; M H Perrin; J Rivier; W W Vale; M J Kuhar
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

2.  In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.

Authors:  C Rivier; J Rivier; K Lederis; W Vale
Journal:  Regul Pept       Date:  1983-01

3.  Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides.

Authors:  K Lederis; A Letter; D McMaster; T Ichikawa; K L MacCannell; Y Kobayashi; J Rivier; C Rivier; W Vale; J Fryer
Journal:  Can J Biochem Cell Biol       Date:  1983-07

4.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin.

Authors:  C Rivier; W Vale
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

5.  Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.

Authors:  E B De Souza
Journal:  J Neurosci       Date:  1987-01       Impact factor: 6.167

6.  Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study.

Authors:  R M Carey; S K Varma; C R Drake; M O Thorner; K Kovacs; J Rivier; W Vale
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

7.  Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.

Authors:  K Lederis; A Letter; D McMaster; G Moore; D Schlesinger
Journal:  Science       Date:  1982-10-08       Impact factor: 47.728

8.  Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells.

Authors:  L M Bilezikjian; W W Vale
Journal:  Endocrinology       Date:  1983-08       Impact factor: 4.736

9.  Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.

Authors:  H J Lenz; L A Fisher; W W Vale; M R Brown
Journal:  Am J Physiol       Date:  1985-07

10.  Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor.

Authors:  P C Wynn; G Aguilera; J Morell; K J Catt
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575
View more
  67 in total

1.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

2.  CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.

Authors:  Eran Gershon; Wylie W Vale
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

3.  Intermale aggression in corticotropin-releasing factor receptor 1 deficient mice.

Authors:  Stephen C Gammie; Sharon A Stevenson
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

4.  Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis.

Authors:  Kendall M Carlin; Wylie W Vale; Tracy L Bale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

5.  Fractal dynamics of heart beat interval fluctuations in corticotropin-releasing factor receptor subtype 2 deficient mice.

Authors:  Oliver Stiedl; Michael Meyer
Journal:  Integr Physiol Behav Sci       Date:  2002 Oct-Dec

6.  Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.

Authors:  J Gulyas; C Rivier; M Perrin; S C Koerber; S Sutton; A Corrigan; S L Lahrichi; A G Craig; W Vale; J Rivier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

9.  Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1).

Authors:  Iman Assil-Kishawi; Tareq A Samra; Dale F Mierke; Abdul B Abou-Samra
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  CRH-stimulation of cyclic adenosine 5'-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2alpha.

Authors:  G Maya-Núñez; C Castro-Fernández; J P Méndez
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.